Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, finding the companies sometimes increased prices of these drugs by 1,000 ...

Here is a hard truth for those of us who are care providers: Americans are unsatisfied with the country's healthcare system.

The term Web Client Runtime Security (WCRS) was coined by the authors to highlight the security or possible malicious ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

As insulin prices in the United States continue to rise, making it increasingly difficult for diabetic patients to afford ...

Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...

Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, has posted a ...